Literature DB >> 25132355

Differential cellular expression of organic anion transporting peptides OATP1A2 and OATP2B1 in the human retina and brain: implications for carrier-mediated transport of neuropeptides and neurosteriods in the CNS.

Bo Gao1, Stephan R Vavricka1,2, Peter J Meier1,3, Bruno Stieger4.   

Abstract

Organic anion transporting polypeptides (OATPs) are polyspecific organic anion transporters, which are expressed in the blood-brain barrier, the choroid plexus, and other organs. The physiologic function of OATPs in extrahepatic tissues remains ambiguous. In rat retina, members of the OATP family are expressed. We therefore investigated the human retina for the expression of OATP1A2 and OATP2B1 and extended the study to human brain. Furthermore, we searched for peptide neurotransmitters as novel OATP substrates. OATP1A2 displayed a broad expression pattern in human retina as assessed by immunofluorescence localization. It is expressed in photoreceptor bodies and somas of amacrine cells. OATP1B2 expression is restricted to the inner nuclear layer and to the inner plexiform layer. Using paraffin sections from human cortex, cerebellum, and hippocampus, OATP1A2 was localized to neurons and neuronal processes, while OATP2B1 is expressed in endothelial cells of brain capillaries. Substance P and vasoactive intestinal peptide were identified as substrates for OATP1A2 and OATP2B1. Double-labeling immunofluorescence of human retina demonstrated the presence of substance P and of vasoactive intestinal peptides in neurons expressing OATP1A2 and OATP2B1, respectively. The expression of OATP1A2 and OATP2B1 in retinal neurons implies a role of these transporters in the reuptake of peptide neurotransmitters released from retinal neurons. The abundant expression of OATP1A2 in brain neurons points to the possibility that OATP1A2 could be involved in the homeostasis of neurosteroids. The high expression of OATP2B1 in brain capillaries supports an important function of OATPs in substance penetration across the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25132355     DOI: 10.1007/s00424-014-1596-x

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  70 in total

Review 1.  Dehydroepiandrosterone sulphate: action and mechanism in the brain.

Authors:  Y Dong; P Zheng
Journal:  J Neuroendocrinol       Date:  2012-01       Impact factor: 3.627

Review 2.  Pharmacogenomics of human OATP transporters.

Authors:  Jörg König; Annick Seithel; Ulrike Gradhand; Martin F Fromm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-09       Impact factor: 3.000

3.  Early development of tyrosine hydroxylase-like and substance P-like immunoreactivity in the human fetal retina.

Authors:  J Nguyen-Legros; C Versaux-Botteri; A Vigny
Journal:  Hum Neurobiol       Date:  1986

4.  Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells.

Authors:  M Suter; C Remé; C Grimm; A Wenzel; M Jäättela; P Esser; N Kociok; M Leist; C Richter
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

5.  Localization of angiotensin converting enzyme in the ciliary epithelium of the rat eye.

Authors:  S M Strittmatter; K M Braas; S H Snyder
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-10       Impact factor: 4.799

6.  Immunoreactive substance P is not part of the retinohypothalamic tract in the rat.

Authors:  Jens Hannibal; Jan Fahrenkrug
Journal:  Cell Tissue Res       Date:  2002-06-21       Impact factor: 5.249

7.  Distribution of rat organic anion transporting polypeptide-E (oatp-E) in the rat eye.

Authors:  Aki Ito; Katsuhiro Yamaguchi; Hiroshi Tomita; Takehiro Suzuki; Tohru Onogawa; Takeaki Sato; Hiroya Mizutamari; Tsuyoshi Mikkaichi; Toshiyuki Nishio; Takashi Suzuki; Michiaki Unno; Hironobu Sasano; Takaaki Abe; Makoto Tamai
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

8.  Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.

Authors:  L M Roberts; D S Black; C Raman; K Woodford; M Zhou; J E Haggerty; A T Yan; S E Cwirla; K K Grindstaff
Journal:  Neuroscience       Date:  2008-06-13       Impact factor: 3.590

9.  L-glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas.

Authors:  C Brandon; D M Lam
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

10.  Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine.

Authors:  Daisuke Sugiyama; Hiroyuki Kusuhara; Hirokazu Taniguchi; Shumpei Ishikawa; Yoshitane Nozaki; Hiroyuki Aburatani; Yuichi Sugiyama
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

View more
  21 in total

Review 1.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 2.  SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers.

Authors:  Marilyn E Morris; Vivian Rodriguez-Cruz; Melanie A Felmlee
Journal:  AAPS J       Date:  2017-06-29       Impact factor: 4.009

3.  Human organic anion transporting polypeptide 1A2 (OATP1A2) mediates cellular uptake of all-trans-retinol in human retinal pigmented epithelial cells.

Authors:  Ting Chan; Ling Zhu; Michele C Madigan; Ke Wang; Weiyong Shen; Mark C Gillies; Fanfan Zhou
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 4.  Functional Expression of P-glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?

Authors:  Wazir Abdullahi; Thomas P Davis; Patrick T Ronaldson
Journal:  AAPS J       Date:  2017-04-26       Impact factor: 4.009

5.  Chicken Organic Anion-Transporting Polypeptide 1A2, a Novel Avian Hepatitis E Virus (HEV) ORF2-Interacting Protein, Is Involved in Avian HEV Infection.

Authors:  Huixia Li; Mengnan Fan; Baoyuan Liu; Pinpin Ji; Yiyang Chen; Beibei Zhang; Yani Sun; Baicheng Huang; Yuchen Nan; Zhenzhao Sun; James P Stewart; Julian A Hiscox; Qin Zhao; En-Min Zhou
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

Review 6.  Transporters in Drug Development: 2018 ITC Recommendations for Transporters of Emerging Clinical Importance.

Authors:  Maciej J Zamek-Gliszczynski; Mitchell E Taub; Paresh P Chothe; Xiaoyan Chu; Kathleen M Giacomini; Richard B Kim; Adrian S Ray; Sophie L Stocker; Jashvant D Unadkat; Matthias B Wittwer; Cindy Xia; Sook-Wah Yee; Lei Zhang; Yan Zhang
Journal:  Clin Pharmacol Ther       Date:  2018-08-08       Impact factor: 6.875

Review 7.  Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery.

Authors:  Kristiina M Huttunen; Tetsuya Terasaki; Arto Urtti; Ahmed B Montaser; Yasuo Uchida
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.580

8.  The neuroprotective effect of latanoprost acts via klotho-mediated suppression of calpain activation after optic nerve transection.

Authors:  Kotaro Yamamoto; Kota Sato; Masayoshi Yukita; Masayuki Yasuda; Kazuko Omodaka; Morin Ryu; Kosuke Fujita; Koji M Nishiguchi; Shigeki Machida; Toru Nakazawa
Journal:  J Neurochem       Date:  2016-12-27       Impact factor: 5.372

9.  Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug.

Authors:  Julia Marschallinger; Iris Schäffner; Barbara Klein; Renate Gelfert; Francisco J Rivera; Sebastian Illes; Lukas Grassner; Maximilian Janssen; Peter Rotheneichner; Claudia Schmuckermair; Roland Coras; Marta Boccazzi; Mansoor Chishty; Florian B Lagler; Marija Renic; Hans-Christian Bauer; Nicolas Singewald; Ingmar Blümcke; Ulrich Bogdahn; Sebastien Couillard-Despres; D Chichung Lie; Maria P Abbracchio; Ludwig Aigner
Journal:  Nat Commun       Date:  2015-10-27       Impact factor: 14.919

10.  siRNA capsulated brain-targeted nanoparticles specifically knock down OATP2B1 in mice: a mechanism for acute morphine tolerance suppression.

Authors:  Zi-Zhao Yang; Li Li; Lu Wang; Ming-Cheng Xu; Sai An; Chen Jiang; Jing-Kai Gu; Zai-Jie Jim Wang; Lu-Shan Yu; Su Zeng
Journal:  Sci Rep       Date:  2016-09-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.